- Release Date: 11/09/13 15:44
- Summary: RELINT: FPH: Disclosure of Director and Officers Relevant Interests
- Price Sensitive: No
- Download Document 9.58KB
FPH 11/09/2013 13:44 RELINT REL: 1344 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Director and Officers Relevant Interests Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities "i) 33,000 options to acquire ordinary shares ii) 8,800 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Deborah Anne BAILEY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 4 September 2013 Consideration paid from acqusition NZ$Nil If the relevant interest was disposed of-- Date of disposal Not applicable Consideration paid for disposal Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place "i) Issue of 33,000 options to acquire ordinary shares ii) Issue of 8,800 Performance Share Rights" E Total number of transactions this notice relates to Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 9 September 2013 Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Products & Technology B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities "i) 132,000 options to acquire ordinary shares ii) 27,500 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Lewis George GRADON D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acqusition 4 September 2013 Consideration paid for acquisition NZ$Nil If the relevant interest was disposed of-- Date of disposal Not Applicable Consideration paid for disposal Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place "i) Issue of 132,000 options to acquire ordinary shares ii) Issue of 27,500 Performance Share Rights" E Total number of transactions this notice relates to Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 9 September 2013 Name of director or officer of public issuer: Paul ANDREASSI Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Quality & Regulatory B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 49,500 options to acquire ordinary shares ii) 13,200 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial interest Name of registered holder of securities Paul ANDREASSI D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4 September 2013 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration paid for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 49,500 options to acquire ordinary shares ii) Issue of 13,200 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 9 September 2013 Name of director or officer of public issuer: Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities "i) 132,000 options to acquire ordinary shares ii) 27,500 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Paul Nigel SHEARER D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue 4 September 2013 Consideration paid from acquisition NZ$Nil If the relevant interest was disposed of-- Date of disposal Not Applicable Consideration received from disposal Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition took place "i) Issue of 132,000 options to acquire ordinary shares ii) Issue of 27,500 Performance Share Rights" E Total number of transactions this notice relates to Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 9 September 2013 Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 82,500 options to acquire ordinary shares ii) 22,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4 September 2013 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal Not applicable Consideration paid for disposal Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 82,500 options to acquire ordinary shares ii) Issue of 22,000 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 9 September 2013 Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT B Securities in public issuer or related body corporate to which this disclosure relates Number, class, and type of securities: "i) 33,000 options to acquire ordinary shares ii) 8,800 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Winston FONG D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 4 September 2013 Consideration paid for acquisition: NZ$Nil If the relevant interest was disposed of-- Date of disposal: Not Applicable Consideration paid for disposal: Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition took place: "i) Issue of 33,000 options to acquire ordinary shares ii) Issue of 8,800 Performance Share Rights" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 9 September 2013 Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director/Chief Executive Officer B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "i) 200,000 options to acquire ordinary shares ii) 30,000 Performance Share Rights" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Michael Grenfell DANIELL D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 4 September 2013 Consideration paid for acquisition NZ$Nil If the relevant interest was disposed of-- Date of disposal Not applicable Consideration received for disposal Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place "i) Issue of 200,000 options to acquire ordinary shares ii) Issue of 30,000 Performance Share Rights" E Total number of transactions this notice relates to Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 9 September 2013 End CA:00240983 For:FPH Type:RELINT Time:2013-09-11 13:44:55
Ann: RELINT: FPH: Disclosure of Director and Offi
Add to My Watchlist
What is My Watchlist?
